Cargando…
Reduced Flow-Mediated Dilatation Is Not Related to COVID-19 Severity Three Months after Hospitalization for SARS-CoV-2 Infection
The coronavirus disease 2019 (COVID-19) pandemic has spread rapidly worldwide, with more than two million deaths. Evidence indicates the critical role of the vascular endothelium in its pathophysiology but, like potential changes in functional vasodilation, the vascular effect of SARS-CoV-2 at a giv...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004847/ https://www.ncbi.nlm.nih.gov/pubmed/33806800 http://dx.doi.org/10.3390/jcm10061318 |
_version_ | 1783671997031514112 |
---|---|
author | Riou, Marianne Oulehri, Walid Momas, Cedric Rouyer, Olivier Lebourg, Fabienne Meyer, Alain Enache, Irina Pistea, Cristina Charloux, Anne Marcot, Christophe de Blay, Frederic Collange, Olivier Mertes, Michel Andrès, Emmanuel Talha, Samy Geny, Bernard |
author_facet | Riou, Marianne Oulehri, Walid Momas, Cedric Rouyer, Olivier Lebourg, Fabienne Meyer, Alain Enache, Irina Pistea, Cristina Charloux, Anne Marcot, Christophe de Blay, Frederic Collange, Olivier Mertes, Michel Andrès, Emmanuel Talha, Samy Geny, Bernard |
author_sort | Riou, Marianne |
collection | PubMed |
description | The coronavirus disease 2019 (COVID-19) pandemic has spread rapidly worldwide, with more than two million deaths. Evidence indicates the critical role of the vascular endothelium in its pathophysiology but, like potential changes in functional vasodilation, the vascular effect of SARS-CoV-2 at a given distance from the acute infection is largely unknown. We assessed brachial artery flow-mediated dilatation (FMD) in 27 COVID-19 patients needing conventional or intensive care unit hospitalization, three months after SARS-CoV-2 infection diagnosis and in nine age- and sex- matched control subjects. Interestingly, the FMD was lower in COVID-19 patients as compared to controls (8.2 (7.2–8.9) vs. 10.3 (9.1–11.7)); p = 0.002, and half of the hospitalized COVID-19 survivors presented with a reduced FMD < 8% at three months of COVID-19 onset. Impaired FMD was not associated with severe or critical SARS-CoV-2 infection, reflected by ICU hospitalization, total hospitalization duration, or severity of lung damage. In conclusion, reduced FMD is often observed even three months after hospitalization for SARS-CoV-2 infection, but such alteration predominantly appears to not be related to COVID-19 severity. Longer and larger follow-up studies will help to clarify the potential prognosis value of FMD among COVID-19 patients, as well as to further determine the mechanisms involved. |
format | Online Article Text |
id | pubmed-8004847 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-80048472021-03-29 Reduced Flow-Mediated Dilatation Is Not Related to COVID-19 Severity Three Months after Hospitalization for SARS-CoV-2 Infection Riou, Marianne Oulehri, Walid Momas, Cedric Rouyer, Olivier Lebourg, Fabienne Meyer, Alain Enache, Irina Pistea, Cristina Charloux, Anne Marcot, Christophe de Blay, Frederic Collange, Olivier Mertes, Michel Andrès, Emmanuel Talha, Samy Geny, Bernard J Clin Med Brief Report The coronavirus disease 2019 (COVID-19) pandemic has spread rapidly worldwide, with more than two million deaths. Evidence indicates the critical role of the vascular endothelium in its pathophysiology but, like potential changes in functional vasodilation, the vascular effect of SARS-CoV-2 at a given distance from the acute infection is largely unknown. We assessed brachial artery flow-mediated dilatation (FMD) in 27 COVID-19 patients needing conventional or intensive care unit hospitalization, three months after SARS-CoV-2 infection diagnosis and in nine age- and sex- matched control subjects. Interestingly, the FMD was lower in COVID-19 patients as compared to controls (8.2 (7.2–8.9) vs. 10.3 (9.1–11.7)); p = 0.002, and half of the hospitalized COVID-19 survivors presented with a reduced FMD < 8% at three months of COVID-19 onset. Impaired FMD was not associated with severe or critical SARS-CoV-2 infection, reflected by ICU hospitalization, total hospitalization duration, or severity of lung damage. In conclusion, reduced FMD is often observed even three months after hospitalization for SARS-CoV-2 infection, but such alteration predominantly appears to not be related to COVID-19 severity. Longer and larger follow-up studies will help to clarify the potential prognosis value of FMD among COVID-19 patients, as well as to further determine the mechanisms involved. MDPI 2021-03-23 /pmc/articles/PMC8004847/ /pubmed/33806800 http://dx.doi.org/10.3390/jcm10061318 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Brief Report Riou, Marianne Oulehri, Walid Momas, Cedric Rouyer, Olivier Lebourg, Fabienne Meyer, Alain Enache, Irina Pistea, Cristina Charloux, Anne Marcot, Christophe de Blay, Frederic Collange, Olivier Mertes, Michel Andrès, Emmanuel Talha, Samy Geny, Bernard Reduced Flow-Mediated Dilatation Is Not Related to COVID-19 Severity Three Months after Hospitalization for SARS-CoV-2 Infection |
title | Reduced Flow-Mediated Dilatation Is Not Related to COVID-19 Severity Three Months after Hospitalization for SARS-CoV-2 Infection |
title_full | Reduced Flow-Mediated Dilatation Is Not Related to COVID-19 Severity Three Months after Hospitalization for SARS-CoV-2 Infection |
title_fullStr | Reduced Flow-Mediated Dilatation Is Not Related to COVID-19 Severity Three Months after Hospitalization for SARS-CoV-2 Infection |
title_full_unstemmed | Reduced Flow-Mediated Dilatation Is Not Related to COVID-19 Severity Three Months after Hospitalization for SARS-CoV-2 Infection |
title_short | Reduced Flow-Mediated Dilatation Is Not Related to COVID-19 Severity Three Months after Hospitalization for SARS-CoV-2 Infection |
title_sort | reduced flow-mediated dilatation is not related to covid-19 severity three months after hospitalization for sars-cov-2 infection |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004847/ https://www.ncbi.nlm.nih.gov/pubmed/33806800 http://dx.doi.org/10.3390/jcm10061318 |
work_keys_str_mv | AT rioumarianne reducedflowmediateddilatationisnotrelatedtocovid19severitythreemonthsafterhospitalizationforsarscov2infection AT oulehriwalid reducedflowmediateddilatationisnotrelatedtocovid19severitythreemonthsafterhospitalizationforsarscov2infection AT momascedric reducedflowmediateddilatationisnotrelatedtocovid19severitythreemonthsafterhospitalizationforsarscov2infection AT rouyerolivier reducedflowmediateddilatationisnotrelatedtocovid19severitythreemonthsafterhospitalizationforsarscov2infection AT lebourgfabienne reducedflowmediateddilatationisnotrelatedtocovid19severitythreemonthsafterhospitalizationforsarscov2infection AT meyeralain reducedflowmediateddilatationisnotrelatedtocovid19severitythreemonthsafterhospitalizationforsarscov2infection AT enacheirina reducedflowmediateddilatationisnotrelatedtocovid19severitythreemonthsafterhospitalizationforsarscov2infection AT pisteacristina reducedflowmediateddilatationisnotrelatedtocovid19severitythreemonthsafterhospitalizationforsarscov2infection AT charlouxanne reducedflowmediateddilatationisnotrelatedtocovid19severitythreemonthsafterhospitalizationforsarscov2infection AT marcotchristophe reducedflowmediateddilatationisnotrelatedtocovid19severitythreemonthsafterhospitalizationforsarscov2infection AT deblayfrederic reducedflowmediateddilatationisnotrelatedtocovid19severitythreemonthsafterhospitalizationforsarscov2infection AT collangeolivier reducedflowmediateddilatationisnotrelatedtocovid19severitythreemonthsafterhospitalizationforsarscov2infection AT mertesmichel reducedflowmediateddilatationisnotrelatedtocovid19severitythreemonthsafterhospitalizationforsarscov2infection AT andresemmanuel reducedflowmediateddilatationisnotrelatedtocovid19severitythreemonthsafterhospitalizationforsarscov2infection AT talhasamy reducedflowmediateddilatationisnotrelatedtocovid19severitythreemonthsafterhospitalizationforsarscov2infection AT genybernard reducedflowmediateddilatationisnotrelatedtocovid19severitythreemonthsafterhospitalizationforsarscov2infection |